Contract Research Organization (CROs) Services Market worth $129.8 billion by 2029

The report "Contract Research Organization (CROs) Services Market by Type (Early Phase, Clinical, Lab, Consulting, Data Management), Therapeutic Area (Cancer, Infectious Disease, Neurology, Dermatology, Immunology, Hematology, Vaccines, CGT) - Global Forecast to 2029", is projected to reach USD 129.8 billion by 2029 from an estimated USD 82.0 billion in 2024, at a CAGR of 9.6% during the forecast period. The rising number of products in the drug development pipeline and growing technological advancements in the clinical trials, are the factors supporting market growth.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167410116&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

Browse 626 market data Tables and 57 Figures spread through 507 Pages and in-depth TOC on "Contract Research Organization (CROs) Services Market by Type (Early Phase, Clinical, Lab, Consulting, Data Management), Therapeutic Area (Cancer, Infectious Disease, Neurology, Dermatology, Immunology, Hematology, Vaccines, CGT) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/contract-research-organization-service-market-167410116.html?utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

Data management subsegment is the fastest-growing of the CRO Services market by type

Among the type subsegments, the market is segmented as Clinical Research Services, Early Phase Development Services, Laboratory Services, Consulting Services and Data Management Services. In 2023, the data management services segment accounted for the highest growth rate of the CRO Services market by type. Growth in this market segment can be attributed to factors such as availability of technically advanced systems for effective data management as well as requirement of efficient data collection, management and analysis for successful conduction of clinical trials.

Medical Device Companies is the fastest-growing segment of the CRO Services market by end user

Among the end user subsegments, the CRO services market is segmented into pharmaceutical & biopharmaceutical companies, medical device companies, and academic institutes. In 2023, medical device companies segment accounted for the fastest-growing subsegment of the end user segment of CRO Services market. Growth in this market segment can be attributed to one of the major factors which is growth in the number of clinical trials conducted for medical devices.

Europe: The second-largest region in the CRO Services market.

The European market is the second-largest CRO Services market globally, mainly due to factors such as growing investment in the pharmaceutical and biotechnology R&D along with presence of players involved in pharmaceutical drug development. Moreover, growing number of clinical trials in the region is another factor supporting the growth of European CRO Services market.

The market for CRO Services is competitive, with key players strategizing to capture the market. Prominent players in the CRO Services market are IQVIA Inc. (US), Laboratory Corporation of America Holdings (US), Thermo Fisher Scientific Inc. (US), ICON Plc (Ireland), WuXi AppTec (China), Syneos Health (US), Charles River Laboratories (US), Pharmaron (China), Fortrea, Inc. (US), Eurofins Scientific (Luxembourg) and Medpace, Inc. (US) among others.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=167410116&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/contract-research-organization-service-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/contract-research-organization-service.asp

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

This release was published on openPR.